Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Marinomed Biotech AG (VI: MARI)

 
MARI Technical Analysis
5
As on 21st Aug 2023 MARI STOCK Price closed @ 41.80 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 64.87 & Strong Sell for SHORT-TERM with Stoploss of 77.90 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MARISTOCK Price

Open 40.10 Change Price %
High 41.80 1 Day 0.70 1.70
Low 40.10 1 Week -0.80 -1.88
Close 41.80 1 Month 2.30 5.82
Volume 46 1 Year -42.20 -50.24
52 Week High 84.00 | 52 Week Low 32.90
 
VI Austria Most Active Stocks
OMV 45.90 -1.50%
EBS 82.95 0.18%
ATS 20.35 7.90%
RBI 29.64 -0.07%
VOE 28.78 -0.42%
WIE 28.66 0.00%
FACC 9.46 1.83%
VER 60.85 0.16%
UQA 12.46 0.32%
BG 112.80 0.36%
 
VI Austria Top Gainers Stocks
ATS 20.35 7.90%
ATS 20.35 7.90%
ATS 20.35 7.90%
ATS 20.35 7.90%
NRE1 8.14 3.17%
ADKO 21.90 2.82%
FQT 61.20 2.34%
FQT 61.20 2.34%
FQT 61.20 2.34%
ROS 47.50 1.93%
 
VI Austria Top Losers Stocks
GAGS 18.00 -21.74%
HED 1.38 -9.21%
OTS 88.50 -3.80%
OTS 88.50 -3.80%
OTS 88.50 -3.80%
STM 53.00 -3.64%
STM 53.00 -3.64%
STM 53.00 -3.64%
STM 53.00 -3.64%
STM 53.00 -3.64%
 
 
MARI
Daily Charts		 MARI
Intraday Charts		 Whats New @
Bazaartrend		 MARI
Free Analysis
 
MARI Important Levels Intraday
RESISTANCE45.08
RESISTANCE44.03
RESISTANCE43.38
RESISTANCE42.73
SUPPORT40.87
SUPPORT40.22
SUPPORT39.57
SUPPORT38.52
 
MARI Forecast September 2025
Share
4th UP Forecast66.85
3rd UP Forecast58.82
2nd UP Forecast53.85
1st UP Forecast48.89
1st DOWN Forecast34.72
2nd DOWN Forecast29.75
3rd DOWN Forecast24.78
4th DOWN Forecast16.75
 
MARI Weekly Forecast
4th UP Forecast50.28
3rd UP Forecast47.56
2nd UP Forecast45.88
1st UP Forecast44.20
1st DOWN Forecast39.40
2nd DOWN Forecast37.72
3rd DOWN Forecast36.04
4th DOWN Forecast33.32
 
MARI Forecast2025
4th UP Forecast148.17
3rd UP Forecast114.06
2nd UP Forecast92.97
1st UP Forecast71.88
1st DOWN Forecast11.72
2nd DOWN Forecast-9.37
3rd DOWN Forecast-30.46
4th DOWN Forecast-64.57
 
 
MARI Other Details
Segment EQ
Market Capital 156351056.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MARI Address
MARI
 
MARI Latest News
 
Your Comments and Response on Marinomed Biotech AG
 
MARI Business Profile
Marinomed Biotech AG, a biopharmaceutical company, develops products for respiratory and ophthalmological diseases in Austria, other European countries, and internationally. It operates through two segments, Carragelose and Marinosolv. The company develops its products based on the Marinosolv, a technology platform that enhances the bioavailability of hardly soluble compounds for the treatment of sensitive tissues, such as eyes, nose, lung, and gastrointestinal tract; and Carragelose, an antiviral respiratory technology platform for the treatment of respiratory tract viral infections, including SARS-Cov-2, as well as offers nasal and throat sprays, and lozenges. It is also developing Budesolv and Tacrosolv targeting inflammatory diseases of nose and eyes; and Flutisolv, a nasal spray for allergic rhinitis. The company was formerly known as Marinomed Biotechnologie GmbH and changed its name to Marinomed Biotech AG in June 2017. Marinomed Biotech AG was incorporated in 2006 and is headquartered in Korneuburg, Austria. Address: Hovengasse 25, Korneuburg, Austria, 2100
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service